Welcome back to another edition of Mystery Infection Files, where we dive deep into the cases that keep infectious disease specialists awake at night.
This month, I'm sharing yet another fascinating case that perfectly illustrates why we should not rely solely on conventional culture methods and how cutting-edge metagenomics is revolutionizing our ability to solve the unsolvable.
The Patient Who Couldn't Catch a Break
The case involved James*, a 67-year-old gentleman whose medical journey reads like a perfect storm of complications.
Diabetes, hypertension, atrial fibrillation: the usual suspects that make any infectious disease case more challenging.
But James had something else: a pattern of devastating embolic strokes over seven years and a recent history that would make any clinician's heart sink.
Just one year before this presentation, James had battled a nightmare scenario – Candida auris fungemia with a bladder fungal ball.
If you've worked with C. auris, you know it's the organism that keeps infection control teams up at night.
The team threw everything at it: his ICD (heart device) had to come out, they performed endoscopic removal of the fungal ball, continuous bladder irrigation with amphotericin, systemic caspofungin for six weeks, fluconazole for a month.
The whole works!
Fast forward to his latest presentation:
Two weeks of abdominal pain with altered mental status.
The initial workup seemed straightforward enough—pyuria with over 1,000 WBCs per hpf, ESBL E. coli UTI, and what appeared to be a small brain hemorrhage on CT.
The team started meropenem, and the abdominal pain resolved beautifully.
But James's mental status? No Change.
This is where the story gets interesting and terrifying.
The Plot Thickens
Repeat brain imaging revealed something that would make any clinician's blood run cold: new ring-enhancing lesions scattered throughout his brain like a constellation of destruction.
Left thalamus, bilateral frontal regions, right parietal lobe — classic cardioembolic pattern screaming "endocarditis."
Here's the kicker: multiple blood cultures were stone cold negative.
The transthoracic echo was unhelpful, no surprise there.
But the TEE? Game changer.
Mobile vegetations on the aortic leaflets with perforation of the non-coronary cusp causing severe aortic regurgitation.
Textbook infective endocarditis, but the blood cultures remained stubbornly NEGATIVE.
This is where traditional medicine hits a wall, but where modern molecular diagnostics shine.
The team was dealing with blood culture-negative endocarditis (BCNE). One of the most challenging scenarios in infectious diseases.
The differential was haunting: could this be recurrent C. auris endocarditis, or were they missing something entirely?
While treating empirically with vancomycin and meropenem, they deployed what I consider our secret weapon: Metagenomic Next Generation sequencing.
This isn't your age-old blood culture.
This technology detects microbial cell-free DNA circulating in the bloodstream. These DNA fragments persists even when the living organisms have been cleared or suppressed by antibiotics.
The Molecular Reveal
The test results came back with a clear answer that no blood culture could provide: Streptococcus gordonii.
This finding completely changed their understanding of the case.
S. gordonii is a viridans group streptococcus with a notorious reputation for causing endocarditis, particularly in patients with underlying cardiac abnormalities.
It's also notoriously difficult to culture, especially in patients who've received antibiotics.
The Resolution
Armed with this molecular diagnosis, the team could provide targeted therapy.
James wasn't a surgical candidate, so they committed to prolonged antimicrobial therapy– vancomycin with meropenem for 7.5 weeks total.
The brain abscesses, which had been over 1 cm in size, gradually shrank to less than 5 mm.
More importantly, his neurologic status improved significantly.
This case embodies everything fascinating about modern infectious diseases medicine.
We're living in an era where traditional culture methods AKA the bedrock of microbiology for over a century, sometimes fall short.
Many of these patients with Blood culture-negative endocarditis without molecular diagnostics, would continue to deteriorate while we treat blindly.
What struck me most about this case was how metagenomics didn't just identify an organism, it identified one that had become unculturable due to prior antibiotics and fastidious growth requirements.
It's particularly powerful in immunocompromised hosts, patients with prior antimicrobial exposure, and complex cases like James's where multiple infections have complicated the clinical picture.
Looking Forward
As we advance into an era of precision medicine, cases like James's remind us that the most powerful diagnostic tool is the right test at the right time.
Metagenomics Sequencing is becoming that right test for an increasing number of our most challenging cases.
The next time you're facing negative blood cultures in a patient with obvious infectious endocarditis, remember this case. 🧠
Watching this case unfold reinforced my belief that we're witnessing a diagnostic revolution.
The integration of molecular diagnostics into routine infectious diseases practice isn't just changing how we diagnose, it's fundamentally changing patient outcomes.
What's your experience with blood culture-negative endocarditis? Have you used metagenomics in your practice? Share your thoughts in the comments below. I'd love to hear about your challenging cases and diagnostic wins.
Acknowledging the Authors and Medical Team Behind This Case:
Nirmal D, Brown B, Silverstein N, et al. (October 03, 2024) Culture-Negative Endocarditis Complicated by Cerebral Abscesses Due to Streptococcus gordonii: A Diagnostic Odyssey. Cureus 16(10): e70775. doi:10.7759/cureus.70775
The details of this case have been shared to educate and inspire healthcare professionals and the broader medical community.
*Patient’s name is fictional to protect privacy
Link to FULL Case Report is referenced in the comments for further reading